Integer - ITGR Stock Forecast, Price & News

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through Medical and Non-Medical segments. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; and arthroscopic, laparoscopic, and general surgery devices and components, such as harmonic scalpels, shaver blades, burr shavers, radio frequency probes, biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment components, and phacoemulsification needles. Further, it provides orthopedic products that include instruments used in hip, knee, and spine surgeries, as well as reamers and chisels. Additionally, the company offers customized battery power and power management systems, and battery solutions for the energy, military, and environmental markets. Furthermore, the company provides medical technologies. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.

Analysts Set New Price Targets

A number of equities research analysts have recently issued reports on ITGR shares. KeyCorp dropped their price target on Integer from $109.00 to $97.00 and set an "overweight" rating for the company in a research report on Friday, July 29th. TheStreet lowered Integer from a "b-" rating to a "c+" rating in a research report on Friday, May 13th. Finally, StockNews.com lowered Integer from a "buy" rating to a "hold" rating in a research report on Monday, April 25th.

Integer Trading Up 2.5 %

Integer stock traded up $1.75 during mid-day trading on Monday, hitting $72.71. The company's stock had a trading volume of 178,905 shares, compared to its average volume of 172,296. The firm has a market capitalization of $2.41 billion, a PE ratio of 31.21 and a beta of 1.22. Integer has a 1 year low of $64.95 and a 1 year high of $100.71. The company has a current ratio of 2.70, a quick ratio of 1.71 and a debt-to-equity ratio of 0.68. The stock's fifty day moving average is $71.03 and its two-hundred day moving average is $76.48.

Integer (NYSE:ITGR - Get Rating) last released its quarterly earnings results on Thursday, July 28th. The medical equipment provider reported $1.04 EPS for the quarter, missing the consensus estimate of $1.18 by ($0.14). Integer had a return on equity of 9.50% and a net margin of 6.10%. The firm had revenue of $350.10 million for the quarter, compared to analysts' expectations of $343.57 million. During the same quarter in the prior year, the business earned $1.07 earnings per share. The company's quarterly revenue was up 12.2% on a year-over-year basis. On average, analysts anticipate that Integer will post 4.3 EPS for the current year.